Inhibition of migration of tumor cells in vitro by lymphokine-containing supernatants.
Lymphokine-containing supernatants derived from seven different human lymphoid cell lines and lymphokine-containing supernatants from concanavalin A-stimulated murine lymphocytes were found to be capable of reversibly inhibiting the migration of tumor cells in vitro. The tumor cell lines used in these studies were the P815 mastocytoma, Ehrlich ascites, Walker carcinosarcoma, Hepatoma 129, and Sarcoma 37. Preliminary physiochemical evidence suggests that the mediator, here termed TMIF, is distinct from MIF. In any case, these results suggest the possibility that lymphokines other than lymphotoxin or macrophage-activating factors may play a role in tumor immunity.
D000818:Animals; D002460:Cell Line; D002464:Cell Migration Inhibition; D002850:Chromatography, Gel; D003208:Concanavalin A / Q000494:pharmacology; D006801:Humans; D008222:Lymphokines / Q000494:pharmacology*; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D051381:Rats; D013154:Spleen / Q000276:immunology; D014462:Ultrafiltration
D008222:Lymphokines; D003208:Concanavalin A